Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.

Murphy K, Nel JS, Moosa MY, Wilson DP, Tsitsi M, Mfinanga S, Kivuyo S, Kyazze D, Alam N, Meintjes G, Eriksson M, Adams J, Menezes C, Variava E, Black J, Bremer M, Dat VQ, Le T, Schutz C, Loyse A, Wake RM, Lawrence DS, Wang D, Jaffar S, Jarvis JN, Harrison TS, Molloy SF, Govender NP

Open source

DOI
10.1186/s13063-026-09520-x
Published
2026 Mar 24
Container
Trials
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s13063-026-09520-x,
  title = {Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.},
  author = {Murphy K and Nel JS and Moosa MY and Wilson DP and Tsitsi M and Mfinanga S and Kivuyo S and Kyazze D and Alam N and Meintjes G and Eriksson M and Adams J and Menezes C and Variava E and Black J and Bremer M and Dat VQ and Le T and Schutz C and Loyse A and Wake RM and Lawrence DS and Wang D and Jaffar S and Jarvis JN and Harrison TS and Molloy SF and Govender NP},
  year = {2026},
  journal = {Trials},
  doi = {10.1186/s13063-026-09520-x},
  url = {https://doi.org/10.1186/s13063-026-09520-x}
}

RIS

TY  - JOUR
TI  - Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.
AU  - Murphy K
AU  - Nel JS
AU  - Moosa MY
AU  - Wilson DP
AU  - Tsitsi M
AU  - Mfinanga S
AU  - Kivuyo S
AU  - Kyazze D
AU  - Alam N
AU  - Meintjes G
AU  - Eriksson M
AU  - Adams J
AU  - Menezes C
AU  - Variava E
AU  - Black J
AU  - Bremer M
AU  - Dat VQ
AU  - Le T
AU  - Schutz C
AU  - Loyse A
AU  - Wake RM
AU  - Lawrence DS
AU  - Wang D
AU  - Jaffar S
AU  - Jarvis JN
AU  - Harrison TS
AU  - Molloy SF
AU  - Govender NP
PY  - 2026
JO  - Trials
DO  - 10.1186/s13063-026-09520-x
UR  - https://doi.org/10.1186/s13063-026-09520-x
ER  - 

APA

K, M., JS, N., MY, M., DP, W., M, T., S, M., S, K., D, K., N, A., G, M., M, E., J, A., C, M., E, V., J, B., M, B., VQ, D., T, L., C, S., A, L., RM, W., DS, L., D, W., S, J., JN, J., TS, H., SF, M., & NP, G. (2026). Fluconazole plus flucytosine versus fluconazole alone for adults with HIV-associated cryptococcal antigenaemia identified through screening: a multi-centre phase III randomised-controlled trial.. Trials. https://doi.org/10.1186/s13063-026-09520-x

Source records